Gary Figiel is a Psychiatry physician affiliated with Emory University. OpenAlex indexes 67 publications with 4,799 citations (h-index 39).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5505 Peachtree Dunwoody Rd NE
Suite 230
Atlanta, GA 303421713
Telephone
404-497-1830Registry record last updated 8 Jul 2007.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Biogen, Inc.Program year20211 payment
- Vanda Pharmaceuticals Inc.Program year20211 payment
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
57.3%Atypical Antipsychotic9.8%Quetiapine Fumarate43%Risperidone22%Olanzapine20%Aripiprazole9%Vraylar3%Lurasidone Hcl2%Clozapine2%Part D<11 patientsSSRI7.4%Escitalopram Oxalate29%Sertraline Hcl24%Trazodone Hcl21%Paroxetine Hcl11%Citalopram Hbr10%Fluoxetine Hcl6%Part D<11 patients+ 24 more classes in this area
Cardiovascular
21.3%Statin6.1%Atorvastatin Calcium55%Simvastatin21%Rosuvastatin Calcium13%Pravastatin Sodium9%Lipitor2%Part D<11 patientsBeta blocker4.3%Metoprolol Succinate35%Carvedilol29%Metoprolol Tartrate20%Atenolol12%Nebivolol Hcl4%Part D<11 patients+ 12 more classes in this area
Metabolism & gastrointestinal
7%Proton pump inhibitor2.1%Pantoprazole Sodium50%Omeprazole44%Esomeprazole Magnesium7%Part D<11 patientsPotassium supplement1.3%Potassium Chloride100%Part D≥24 patients+ 11 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Altered Mental Status as a Novel Initial Clinical Presentation for COVID-19 Infection in the Elderly
American Journal of Geriatric Psychiatry
2020 - A systematic review of the effectiveness of rivastigmine for the treatment of behavioral disturbances in dementia and other neurological disorders
Current Medical Research and Opinion
2007 - Inhibition of return in children with perinatal brain injury
Journal of the International Neuropsychological Society
2001 - The Use of Rapid-Rate Transcranial Magnetic Stimulation (rTMS) in Refractory Depressed Patients
Journal of Neuropsychiatry
1998
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Guyton, MD
Emory University
Keith Delman, MD
Emory University
Paolo Raggi, MD
Emory University
Monica Farley, MD
Emory University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”